{"organizations": [], "uuid": "46b2f580589a0b0809357ee2426846fbc81d090f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-acquis/brief-boston-scientific-announces-acquisition-of-nvision-medical-corp-idUSASC09VVU", "country": "US", "domain_rank": 408, "title": "BRIEF-Boston Scientific Announces Acquisition Of NVision Medical Corp", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T13:41:00.000+03:00", "replies_count": 0, "uuid": "46b2f580589a0b0809357ee2426846fbc81d090f"}, "author": "", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-acquis/brief-boston-scientific-announces-acquisition-of-nvision-medical-corp-idUSASC09VVU", "ord_in_thread": 0, "title": "BRIEF-Boston Scientific Announces Acquisition Of NVision Medical Corp", "locations": [], "entities": {"persons": [], "locations": [{"name": "boston", "sentiment": "none"}], "organizations": [{"name": "brief-boston scientific announces acquisition of nvision medical corp", "sentiment": "negative"}, {"name": "brief-boston scientific announces acquisition of nvision medical corp reuters", "sentiment": "negative"}, {"name": "staff    boston scientific corp", "sentiment": "none"}, {"name": "boston scientific corp", "sentiment": "none"}, {"name": "scientific corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Boston Scientific Corp:\n* BOSTON SCIENTIFIC ANNOUNCES ACQUISITION OF NVISION MEDICAL CORPORATION\n* BOSTON SCIENTIFIC-DEAL CONSISTS OF CASH PAYMENT OF $150 MILLION, AND UP TO ADDITIONAL $125 MILLION IN POTENTIAL CLINICAL & COMMERCIAL MILESTONES OVER 4 YEARS\n* BOSTON SCIENTIFIC CORP - ACQUISITION IS EXPECTED TO BE IMMATERIAL ON AN ADJUSTED BASIS IN 2018 AND 2019\n* BOSTON SCIENTIFIC CORP - ACQUISITION IS EXPECTED TO BE DILUTIVE ON A GAAP BASIS THROUGH 2020 AND LESS ACCRETIVE THEREAFTER DUE TO COSTS\n* BOSTON SCIENTIFIC CORP - ACQUISITION IS EXPECTED TO BE ACCRETIVE ON AN ADJUSTED BASIS AFTER 2018 AND 2019 Source text for Eikon:\nOur ", "external_links": [], "published": "2018-04-16T13:41:00.000+03:00", "crawled": "2018-04-16T13:49:13.034+03:00", "highlightTitle": ""}